The first generic drug maker to launch after a patent expires captures up to 90% of the market - and keeps most of it for years. Here’s how the Hatch-Waxman Act creates lasting dominance.
Read MoreTag: generic market share
First-Mover Advantage: How First Generic Drug Makers Dominate the Market
Archive
Categories
Buspirone vs. Other Anxiety Medicines: A Straight‑Forward Comparison
A clear, conversational guide that compares Buspirone with common anxiety drugs, covering benefits, risks, onset time, and which scenarios each option fits best.
State Laws on NTI Substitution: Varying Requirements Across the US
State laws on NTI drug substitution vary widely across the U.S., with 27 states restricting generic swaps for medications like warfarin and levothyroxine. While the FDA says generics are safe, patient safety concerns are driving state-level rules - and a national shift is coming.
Inositol Nicotinate: Boost Your Well‑Being with the Modern Dietary Supplement
Discover how inositol nicotinate, a vitamin B complex supplement, enhances mood, metabolism, and overall well‑being for today’s busy lifestyle.
Dipyridamole vs Alternatives: Benefits, Risks, and When to Use
A detailed comparison of dipyridamole with clopidogrel, aspirin, warfarin and other alternatives, covering mechanisms, uses, side effects, interactions and when to choose each drug.
First-Episode Psychosis: Why Early Intervention and Family Support Save Lives
First-episode psychosis can be turned around with early intervention and family support. Learn how coordinated care, low-dose meds, therapy, and family education improve recovery-and why waiting makes things worse.